Breaking News

PharmaForm Signs Formulation Services Pact

Akela Pharma's wholly owned subsidiary, PharmaForm, has signed a development agreement with an undisclosed global pharmaceutical company, to develop specialized oral dosage forms at its Austin, TX facility.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Akela Pharma’s wholly owned subsidiary, PharmaForm, has signed a development agreement with an undisclosed global pharmaceutical company, to develop specialized oral dosage forms at its Austin, TX facility. Under the terms of the agreement, PharmaForm will provide contract formulation services to develop products in one or more therapeutic areas using its expertise in hot melt extrusion. PharmaForm will be entitled to royalty payments upon product commercialization....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters